Investors Research Corp Hookipa Pharma Inc. Transaction History

Investors Research Corp

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2021 Apr 28, 2021	SELL	$10.64 - $14.7 $31 - $44	-3 Reduced 3.61%	80 $1,000
Q3 2020 Oct 20, 2020	BUY	$8.59 - $11.89 $712 - $986	83 New	83 $1,000

624K

Ticker HOOK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,654,500
Market Cap $44.9M
Description
HOOKIPA Pharma Inc., a clinical stage biopharmaceutical company, develops immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform. The company's lead infectious disease product candidate is HB-101, which is in a randomized double-blinded Phase II clinical trial in patients awaiting kidney transpl...

Get notified when there are updates to the investment portfolio of Investors Research Corp, based on Form 13F filings with the SEC.

Stay updated on Investors Research Corp with notifications on news.